Professional
Added to YB: 2024-11-08
Pitch date: 2024-10-18
DXCM [bullish]
DexCom, Inc.
+0.56%
current return
Author Info
No bio for this author
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.
Market Cap
$27.1B
Pitch Price
$71.87
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.11
P/E
33.71
EV/Sales
5.69
Sector
Health Care Equipment and Supplies
Category
growth
Aristotle Focus Growth Portfolio Holding: DexCom, Inc.
DXCM: Q3 earnings miss due to DME channel share loss, early insurance rebate threshold, and salesforce realignment slowing new patient starts. Management addressing execution issues, maintaining 15%+ long-term growth target. Attractive valuation given strong growth profile.
Read full article (1 min)